Sara Pahlavan Ph.D.
Department of Stem Cells and Developmental Biology
Sara Pahlavan is a member of Royan Cardiovascular Group. She studied Biology in her B.Sc and graduated in M.Sc of Physiology from Shiraz University. During her undergraduate studies, she got interested in physiology of cardiac cells, specifically excitation-contraction coupling. To pursue her interest, she moved to Germany and started her graduate studies in Professor Peter Lipp’s lab at Universitäts Klinikum des Saarlandes.
There, she learned state of the art technologies such as simultaneous “patch-clamp” and “Ca2+ imaging” to study excitation-contraction coupling in cardiomyocytes. Furthermore, she used transgenic mice to study pathophysiology of inherited cardiac diseases with respect to electrophysiology and/or Ca2+ machinery.
Toward the end of her PhD studies, she got interested in using patient-specific iPSC-derived cardiomyocytes to study cardiac disease in human cardiac cells and to test new drugs. To pursue this goal, she moved to United States and started her postdoctoral fellowship in Professor Martin Morad’ lab at Medical University of South Carolina.
There she could develop a new genetically-encoded Ca2+ probe to study Ca2+ induced Ca2+ release and Ca2+ sparks in cardiomyocytes of healthy and patient-specific iPSC-derived cardiomyocytes. She joined Royan Institute at 2015 and currently she works as an Assistant Professor in cardiovascular Group.
Physiology/ Disease Modeling/ Drug Testing
Dr. Pahlavan’s research focuses on the mechanistic studies of cardiovascular diseases using in vitro models. Both 2D human pluripotent stem cells-derived cardiomyocytes (hPSC-CM) and 3D cardiac micro-tissues are used by her group to model pathological conditions such as hypoxia and fibrosis, and to explore the therapeutic approaches. In line with that, part of her research is directed toward maturation of hPSC-CM and development of more native-like cardiac micro-tissues. She uses a combination of tissue engineering and stem cell biology to improve this 3D cardiac tissues. Furthermore, she is interested in regenerative approaches for heart by dedifferentiation of cardiomyocytes. And she uses in vitro platforms to find the major molecular players of dedifferentiation.
Project title: Investigations into the roles of caspase regulators during differentiation of human embryonic stem cells into cardiomyocytes
Project title: Safety and Feasibility of Intracoronary Transplantation of Allogenic Wharton’s Jelly Derived-Mesenchymal Stem Cells (WJ-MSCs) in Pediatrics with Non-Ischemic Dilated Cardiomyopathy (PNIDCM): Clinical Trial Phase I
Project title: Differentiation of cardiac fibroblast cells from human pluripotent stem cells and their use in in vitro fibrosis model
Malihe Rezaei, MD
Project title: Generation and Expansion of Cardiac Progenitor Cells derived from Human Pluripotent Stem Cells using Small Molecules
Project title: Study of miRNAs in cell cycle arrest of human pluripotent stem cell-derived cardiomyocyte
2023 Roshanravan N, Ghaffari S, Bastani S, Pahlavan S, Asghari S, Doustvandi MA, Jalilzadeh-Razin S, Dastouri M. Human cardiac organoids: A recent revolution in disease modeling and regenerative medicine. J Cardiovasc Thorac Res 2023;15(2):68-72
2023 Sadeghi H, Masoudi M, Torabi P, Rezaeiani S, Movahedi F, Pahlavan S, Moradi S. Conditioned media from human pluripotent stem cell‐derived cardiomyocytes inhibit the growth and migration of lung cancer cells. Journal of Cellular Biochemistry. 2023; 124(3):446–458
2022 Hesaraki M, Bora U, Pahlavan S, Salehi N, Mousavi SA, Barekat M, Rasouli SJ, Baharvand H, Ozhan G, Totonchi M. A Novel Missense Variant in Actin Binding Domain of MYH7 Is Associated With Left Ventricular Noncompaction. Front Cardiovasc Med. 2022 Apr 8;9:839862. doi: 10.3389/fcvm.2022.839862
2021 Radmanesh F, Sadeghi Abandansari H, Ghanian MH, Pahlavan S, Varzideh F, Yakhkeshi S, Alikhani M, Moradi S, Braun T, Baharvand H. Hydrogel-mediated delivery of microRNA-92a inhibitor polyplex nanoparticles induces localized angiogenesis. Angiogenesis. 2021 Aug;24(3):657-676. doi: 10.1007/s10456-021-09778-6
2021 Melika Parchehbaf-Kashani, Hassan Ansari, Elena Mahmoudi, Maryam Barekat, Mohammadmajid Sepantafar, Sarah Rajabi, Sara Pahlavan. Heart Repair Induced by Cardiac Progenitor Cell Delivery within Polypyrrole-Loaded Cardiogel Post-ischemia. ACS Applied Bio Materials. 4, 6, 4849–4861
2021 Shiva Ahmadvand, Ali Osia, Anna Meyfour, Sara Pahlavan. Gender-specific characteristics of hypertrophic response in cardiomyocytes derived from human embryonic stem cells. J Cardiovasc Thorac Res 13(2). 146-155
2021 Montazeri L, Kowsari-Esfahan R, Pahlavan S, et. al. Oxygen-rich Environment Ameliorates Cell Therapy Outcomes of Cardiac Progenitor Cells for Myocardial Infarction. Materials Science and Engineering: C 121, 111836
2020 Baei P, Hosseini M, Baharvand H,Pahlavan S. Electrically conductive materials for in vitro cardiac microtissue engineering.J Biomed Mater Res A. 2020 Feb 8. doi: 10.1002/jbm.a.36894.
My interview with prestigeous Daneshmand magezine
New Year Ceremony 1398
Heart group 1397
New Year Celebration
Our Heart group
Our Tehran Sightseeing
New Year Celebration
Cell therapy to treat heart in NEWS
Lecture by Dr. Sara Pahlavan in Bishnash 99
Coffee shop day; after 2 years qarantine
Teachers Day 1402, happy to have such wonderful group members
Currently I do not have open positions for graduate students.
Volunteers are welcome to join my group.